 |
62 Diseases |  |
26 Trials |
|
26 Trials |  |
826 News |  |
| «12345678910 |
- | Levemir (insulin detemir rDNA origin) / Novo Nordisk
New P1 trial: Pharmacodynamics and Pharmacokinetics of Insulin Detemir in Subjects With Type 2 Diabetes (clinicaltrials.gov) - Dec 19, 2011
P1, N=15, Completed, Sponsor: Novo Nordisk
- | Levemir (insulin detemir rDNA origin) / Novo Nordisk
New P1 trial: Within-subject Variability of Insulin Detemir in Healthy Volunteers (clinicaltrials.gov) - Dec 19, 2011
P1, N=40, Completed, Sponsor: Novo Nordisk
- Levemir (insulin detemir rDNA origin) / Novo Nordisk
New P1 trial: Comparison of Insulin Detemir Produced by the Current Process and the NN729 Process in Healthy Subjects (clinicaltrials.gov) - Dec 8, 2011
P1, N=37, Completed, Sponsor: Novo Nordisk A/S
- || Levemir (insulin detemir rDNA origin) / Novo Nordisk
Enrollment change: KILOS: Observational Study on Levemir (clinicaltrials.gov) - Dec 7, 2011
P=N/A, N=365, Completed, Sponsor: Novo Nordisk
N=525 --> 365
- | Levemir (insulin detemir rDNA origin) / Novo Nordisk
New P4 trial: Comparing Efficacy and Safety of Insulin Detemir Plus Insulin Aspart and NPH Insulin Plus Human Soluble Insulin With or Without Metformin in Chinese Patients With Type 2 Diabetes (clinicaltrials.gov) - Dec 5, 2011
P4, N=58, Terminated, Sponsor: Novo Nordisk
- |||||||||| Levemir (insulin detemir rDNA origin) / Novo Nordisk
New P3 trial: Comparison of Insulin Detemir Plus Insulin Aspart With Insulin NPH Plus Human Soluble Insulin in Subjects With Type 1 Diabetes (clinicaltrials.gov) - Dec 4, 2011
P3, N=598, Completed, Sponsor: Novo Nordisk
- |||| Levemir (insulin detemir rDNA origin) / Novo Nordisk
Trial completion, Combination therapy: Impact of Dietary Intervention on Weight Change in Subjects With Type 2 Diabetes (clinicaltrials.gov) - Dec 4, 2011
P4, N=611, Completed, Sponsor: Novo Nordisk
N=525 --> 365 Active, not recruiting --> Completed
- ||| Levemir (insulin detemir rDNA origin) / Novo Nordisk
Clinical: An Observational Study of Insulin Aspart and, if Necessary, Insulin Levemir (FlexPen®) in the Evening or at Bedtime (clinicaltrials.gov) - Nov 24, 2011
P=N/A, N=2134, Completed, Sponsor: Novo Nordisk
- | Lantus (insulin glargine) / Sanofi, Levemir (insulin detemir rDNA origin) / Novo Nordisk
Enrollment open: Comparing Long-acting Insulins During Exercise in Type 1 Diabetes (clinicaltrials.gov) - Nov 6, 2011
P4, N=30, Recruiting, Sponsor: Buckinghamshire Healthcare NHS Trust
Active, not recruiting --> Completed Not yet recruiting --> Recruiting
- Levemir (insulin detemir rDNA origin) / Novo Nordisk
Trial completion: Comparing the Metabolic Control of Once to Twice-daily Insulin Detemir Injections (clinicaltrials.gov) - Oct 31, 2011
P4, N=50, Completed, Sponsor: Rabin Medical Center
Not yet recruiting --> Recruiting Active, not recruiting --> Completed
- Levemir (insulin detemir rDNA origin) / Novo Nordisk
New P3 trial: Effect of NPH Insulin, Insulin Detemir and Insulin Glargine on GH-IGF-IGFBP Axis (clinicaltrials.gov) - Oct 26, 2011
P3, N=19, Completed, Sponsor: University of Aarhus
- Lantus (insulin glargine) / Sanofi, Levemir (insulin detemir rDNA origin) / Novo Nordisk
Trial completion: Insulin Detemir Compared to Insulin Glargine: Appetite and Calories Consumed in Type 1 Diabetes (clinicaltrials.gov) - Oct 3, 2011
P=N/A, N=10, Completed, Sponsor: University of New Mexico
Active, not recruiting --> Completed Recruiting --> Completed
- |||| Levemir (insulin detemir rDNA origin) / Novo Nordisk
Trial completion, Surgery: Transitioning Open Heart Surgery Patients From Insulin Infusions to Detemir (clinicaltrials.gov) - Sep 29, 2011
P4, N=82, Completed, Sponsor: Ohio State University
Recruiting --> Completed Active, not recruiting --> Completed
- | Lantus (insulin glargine) / Sanofi, Levemir (insulin detemir rDNA origin) / Novo Nordisk
New P4 trial: Comparing Long-acting Insulins During Exercise in Type 1 Diabetes (clinicaltrials.gov) - Sep 19, 2011
P4, N=30, Recruiting, Sponsor: Buckinghamshire Healthcare NHS Trust